The aim of this study was to report the concordance of BRCA1/2 pathogenic/likely pathogenic variants detected in germline and tumour DNA in a large, real-world cohort of patients treated for epithelial ovarian cancer at our specialist oncological referral centre. Here, BRCA1 is linked to neoplasm.